Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

NHS relaxes rules on weight-loss jabs for millions of diabetes patients

Summary
Millions more NHS patients could be offered Ozempic or Mounjaro in the biggest overhaul in diabetes treatment for a decade. The National Institute of Health and Care Excellence (Nice), the NHS medicines watchdog, has issued new draft guidance calling for the use of GLP-1 jabs, first developed for diabetes but now widely used for weight loss, to be ramped up significantly.

8 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Independent broke the news in London, United Kingdom on Tuesday, August 19, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal